SOURCE: Visualant, Inc.

Visualant, Inc.

August 27, 2013 08:31 ET

Visualant to Present at the 2013 Gateway Conference on September 10

SEATTLE, WA--(Marketwired - Aug 27, 2013) - Visualant, Inc. (OTCQB: VSUL), a leading provider of chromatic-based identification and diagnostic solutions, has been invited to present at the 2013 Gateway Conference being held on Tuesday, September 10, 2013 at the Palace Hotel in San Francisco.

Visualant CEO Ron Erickson is scheduled to present at 2:30 p.m. Pacific time, with one-on-one meetings held throughout the day. He will discuss the company's upcoming launch of its breakthrough ChromaID technology that uses light to identify, detect, or diagnose materials that cannot be identified by the human eye.

For additional information or to schedule a one-on-one meeting with Visualant management, visit and click on the Register/Login tab. You may also email your request to or call Matt Glover at 949-574-3860.

About Visualant, Inc.
Visualant™ is a public company whose shares trade under the stock symbol "VSUL." The Visualant Spectral Pattern Matching™ technology directs structured light onto a substance, through a liquid/gas, or off a surface, to capture a unique ChromaID™. When matched against existing databases, a ChromaID can be used to identify, detect, or diagnosis markers invisible to the human eye. ChromaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab-based tests.

Visualant has a Joint Development Agreement through December 31, 2013 with Sumitomo Precision Products Co., Ltd. ("SPP"), which focuses on the commercialization of the SPM technology and an ongoing License Agreement providing SPP with an exclusive license of the SPM technology in identified Asian territories. For more information, visit

Contact Information

  • Investor Contacts
    Scott Liolios or Matt Glover
    Liolios Group Investor Relations
    EmailEmail Contact
    Phone +1 (949) 574-3860